There is a large body of evidence that indicated Nrf2 promoted proliferation, invasion, and chemoresistance by determining its expression in kinds of cancer including human hepatocellular carcinoma (HCC) cells 6, 8, 9. The gene discussed is NFE2L2; the disease is cancer.